Gustav Christensen

Presidente en

Phytera, Inc.

78 años

54 relaciones

Health Technology

Finance

Consumer Services

Perfil

Gustav A. Christensen is currently Chairman at Morphic Therapeutic, Inc. and President, Treasurer & Director at Phytera, Inc. Former roles include Chairman at Morphic Holding, Inc. (2016–2024), Independent Director at Generation Bio Co. (2017–2026), President, Chief Executive Officer & Director at Dyax Corp.
(2011–2016), Managing Director at Apeiron Partners LLC (2005–2007), Vice President-Business Development at Genetics Institute LLC (1983–1988), Vice President-Operations Fenwal Laboratories at Baxter International, Inc. (1976–1983), Chairman at Alpha-Beta Technology, Inc., President at ImmuLogic Pharmaceutical Corp., Advisor at BioVentures Investors, and Member-Management Board at Alantos Pharmaceuticals AG.
Education includes graduate studies at the University of Aarhus and an MBA from Harvard Business School.

Cargos activos de Gustav Christensen

Empresas	Cargo	Inicio
Phytera, Inc. Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops plant-based and marine-based pharmaceuticals	Presidente	-
Morphic Therapeutic, Inc. Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors	Presidente	-

Todos los cargos activos de Gustav Christensen

Antiguos cargos conocidos de Gustav Christensen.

Empresas	Cargo	Fin
GENERATION BIO CO.	Director/Miembro de la Junta	06/02/2026
MORC HOLD	Presidente	16/08/2024
DYAX CORP.	Director Ejecutivo	22/01/2016
BioVentures Investors BioVentures Investors Investment ManagersFinance BioVentures invests in companies located in the United States. The firm focuses on the health care and medtech sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 25 million. It also takes a seat on the board of directors.	Inversor de Capital Privado	31/03/2009
Apeiron Partners LLC Apeiron Partners LLC Investment ManagersFinance Provides investment advice	Corporate Officer/Principal	01/01/2007

Ver el detalle de la experiencia de Gustav Christensen.

Formación de Gustav Christensen.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Gustav Christensen.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	14
Baxter International, Inc. Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services	Health Technology
Genetics Institute LLC Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
ImmuLogic Pharmaceutical Corp. ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Alpha-Beta Technology, Inc. Alpha-Beta Technology, Inc. Electronic ComponentsElectronic Technology Discovers, develops and commercialization of novel carbohydrate-based products	Electronic Technology
Dyax Corp. Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics	Health Technology
Phytera, Inc. Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops plant-based and marine-based pharmaceuticals	Commercial Services
BioVentures Investors BioVentures Investors Investment ManagersFinance BioVentures invests in companies located in the United States. The firm focuses on the health care and medtech sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 25 million. It also takes a seat on the board of directors.	Finance
University of Aarhus University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Alantos Pharmaceuticals AG Alantos Pharmaceuticals AG BiotechnologyHealth Technology Develops and manufactures molecule pharmaceuticals for arthritic and metabolic diseases	Health Technology
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Apeiron Partners LLC Apeiron Partners LLC Investment ManagersFinance Provides investment advice	Finance
Morphic Therapeutic, Inc. Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors	Health Technology
Morphic Holding, Inc. Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs	Health Technology
Generation Bio Co. Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines	Health Technology